Back to Journals » Journal of Asthma and Allergy » Call For Papers

Journal of Asthma and Allergy

ISSN: 1178-6965


The following Article Collections/ Thematic Series are currently open for submissions:

Atopic Dermatitis and Other Atopic Comorbidities

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Atopic Dermatitis and Other Atopic Comorbidities” in the Journal of Asthma and Allergy.

Atopic dermatitis (AD) is a chronic inflammatory cutaneous disorder. Currently, AD has been found to be associated with substantial patient burden and numerous atopic comorbidities, including asthma, allergic rhinitis, food allergy, and eosinophilic esophagitis, as well as nonatopic comorbidities, including allergic contact dermatitis, anxiety, depression, suicidality, infections, and cardiovascular disease. All these comorbidities led to the recognition of AD as a systemic disease. Of note, the relationship between AD and comorbidities is likely bidirectional and multifactorial, as well as some comorbidities may be secondary to the effects of the burden of chronic AD.

This Article Collection aims to explore the association between atopic dermatitis and other atopic comorbidities, shedding light on the shared pathophysiological mechanisms and the implications for clinical management.

This Article Collection aims to bring together original research articles, review articles, and commentaries exploring the pathogenesis of atopic diseases, also considering primary immune defects presenting as AD, the role of environmental factors, the impact of environmental allergies and infections, novel diagnostic approaches (including biomarkers), and emerging therapeutic approaches (including biologic treatments and JAK inhibitors). Articles regarding all the atopic diseases (asthma, food allergy, allergic rhinitis, eosinophilic esophagitis, and atopic dermatitis) are welcome.

Potential topics include the following aspects:
- Epidemiology and burden of atopic comorbidities
- Pathophysiological mechanisms
- The role of environmental allergies in atopic diseases
- Biomarkers in atopic diseases
- Asthma and allergic rhinitis in atopic dermatitis
- Atopic dermatitis and food allergies
- Atopic dermatitis and mental health
- Novel therapeutic approaches
- The use of biologics in atopic diseases
- Clinical management and guidelines

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

The deadline for submissions is 31 December 2024.

Please submit your manuscript on our website, quoting the promo code DFHHN to indicate that your submission is for consideration in this Article Collection.

Guest Advisors
Maddalena Napolitano, Professor, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
[email protected]

Luca Potestio, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
[email protected]

Cataldo Patruno, Professor, MD, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro
[email protected]

View all papers in this article collection

Wheezing in Preschool Children: From Origins to Outcomes

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Wheezing in Preschool Children: From Origins to Outcomes” in the Journal of Asthma and Allergy.

Wheezing is very common in children under 6 years. Beyond allergens and irritants, respiratory infections are the main triggers of wheezing, as demonstrated by the significant reduction of wheezing exacerbations during the COVID-19 pandemic in which the circulation of common respiratory viruses was significantly reduced. 

Despite the existence of asthma predictive tools, the natural evolution of wheezing is uncertain since not all children with wheezing will develop asthma in later age. Wheezing is a heterogeneous disease with many risk factors and many clinical phenotypes. Despite the difficulty in performing certain examinations in young children, different underlying pathophysiological mechanisms have been also found and described as specific endotypes. However, more research is needed to identify children with severe phenotypes and at a higher risk of asthma. Strategies to prevent respiratory infections might be helpful to reduce the burden of wheezing in preschool age. 

Preschool wheezing is associated with a significant burden, both for families and pediatricians in their daily clinical practice. Most children are treated with medications, sometimes including steroids, and some need hospitalization for severe attacks. Diagnosis and management may be improved by better describing phenotypes and endotypes with measurable biomarkers and lung function tests. The management of daily therapies and acute attacks can be very demanding for caregivers; moreover, they must be provided education, wheezing plans, and support. More research is needed on parental- and caregiver-reported outcomes. 

The purpose of this Article Collection is to outline and discuss: a) the recent advances on phenotypes and endotypes of preschool wheezing; b) the role of virus and bacteria in its pathogenesis; c) the management not only of the acute attack but also of daily symptoms with particular attention to support caregivers and their needs; d) the feasibility of lung function tests and other assessments to identify wheezing characteristics; and e) the need and the timing for specialist referral and invasive investigations. 

All data on preschool wheezing are accepted: epidemiological studies, cohort studies, or randomized controlled trials, but also reviews on a particular subtopic like pathogenesis, diagnosis, or management.

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code TRNZO to indicate that your submission is for consideration in this Article Collection.

The deadline for submitting manuscripts is 31 December 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

Guest Advisors

Prof. Susanna Esposito, University of Parma

[email protected]

Full Professor of Pediatrics, Director of the Specialty School of Pediatrics, Chief of the Third Mission Committee and Director of the Pediatric Clinic. She is President of the World Association for Infectious Diseases and Immunological Disorders and Chair of the Technical Committee in Infectious Diseases and Vaccination of the Italian Society of Pediatrics. Her research activities have led to the publication of more than 1,000 articles (PubMed) with an h-index of 82 (Scopus) and an IF >5,000.

Dr. Valentina Fainardi, University of Parma

[email protected]

Researcher in Pediatric pulmonology and Cystic fibrosis at the University of Parma. She is a member of the Italian Society of Pediatric Pulmonology (SIMRI) and European Respiratory Society (ERS).

View all papers in this article collection

Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology” in the Journal of Asthma and Allergy.

Recurrent pulmonary infections may occur due to a number of underlying conditions and also among normal hosts. To further our understanding of recurrent infections, this Article Collection will be published. Recurrent pulmonary infections occur when the immune system is unable to effectively clear a pathogen. Examples of such chronic infections include tuberculosis, pneumonia, sinusitis, rhinitis, and influenza. Though recurrent pulmonary infections may occur in any individual, typically those with underlying conditions such as pulmonary structural abnormalities, primary or secondary immunodeficiencies, or congenital diseases like cystic fibrosis (CF), are affected the most. Other common sources of recurrent pulmonary infections include ciliary defects (both primary and secondary), aspiration, foreign body presence, and bronchiectasis. The pathophysiology, diagnosis, and treatment of recurrent pulmonary infections will be further explored in this Collection.

The Editors welcome relevant clinical Original Research, Reports, Editorials, Commentaries, and Case Series. These articles may pertain broadly to the field of recurrent pulmonary infections, though special attention will be given to the following subareas:

  • Recurrent pulmonary infections caused by aspiration or presence of foreign body
  • Primary and secondary ciliary defects and the role they play in recurrent infection
  • Diagnosis and treatment of both CF and non-CF bronchiectasis
  • Recurrent infections due to primary and secondary immunodeficiencies
  • Imaging studies to detect recurrent pulmonary infections
  • Structural abnormalities, including esophageal disorders, of the pulmonary system
  • Infections due to transplant-associated immunodeficiency
  • Prevention of pulmonary infection recurrence
  • Novel diagnostic criteria or biomarkers associated with recurrent pulmonary infections
  • Case reports of recurrent pulmonary infections with novel pathophysiology or treatment plan
  • Cases of tuberculosis and non-tuberculosis mycobacterial infection

Keywords:

  • Recurrent pulmonary infections
  • Immunodeficiency
  • congenital disease
  • ciliary defects
  • bronchiectasis

Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 28 February 2025.

Please submit your manuscript on our website, quoting the promo code GIYJF to indicate that your submission is for consideration in this Article Collection.

 

View all papers in this article collection


Call For Papers

Editor-in-Chief: Amrita Dosanjh, MD


To see where the Journal of Asthma and Allergy is indexed online view the Journal Metrics.

What is the advantage to you of publishing in the Journal of Asthma and Allergy?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although the Journal of Asthma and Allergy receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors.  The Journal of Asthma and Allergy has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed
The Journal of Asthma and Allergy is indexed on PubMed Central (title abbreviation: J Asthma Allergy). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Amrita Dosanjh, MD
Editor-in-Chief
Journal of Asthma and Allergy

Email: Editor-in-Chief